Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01597388
Title AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

breast cancer

Therapies

Fulvestrant + Vistusertib

Age Groups: adult
Covered Countries USA


No variant requirements are available.